Crizotinib Produced Robust Response in ALK-Positive Pediatric Lymphoma

Pediatric patients with ALK-positive anaplastic large cell lymphomas and inflammatory myofibroblastic tumors had strong responses to treatment with crizotinib.

Source: CancerNetwork - August 23, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Hematologic Malignancies Leukemia & Lymphoma News Pediatric Cancers Source Type: news